phrykt

Bristol Myers Squibb (BMY) cash: $10.2B

Bristol Myers Squibb held $10.2B in cash and cash equivalents on Dec 31, 2025, down 1.3% from $10.3B a year earlier.

From Bristol Myers Squibb's filings with the SEC · Read the filing · BMY stock page

Bristol Myers Squibb cash by year

$14B2021$9.1B2022$11.5B2023$10.3B2024$10.2B2025

#60 of 4,171 US companies by cash · See the full ranking

Year endedCashChange
Dec 31, 2025$10.2B-1%
Dec 31, 2024$10.3B-10%
Dec 31, 2023$11.5B+26%
Dec 31, 2022$9.1B-35%
Dec 31, 2021$14B–

Cash of similar companies

Companies in the same industry as Bristol Myers Squibb, by SEC industry code, with the closest cash. Each name opens the same page for that company.

CompanyCash, latest yearYear ended
Johnson & Johnson$19.7BDec 28, 2025
Merck$14.6BDec 31, 2025
Bristol Myers Squibb$10.2BDec 31, 2025
Abbott Laboratories$8.5BDec 31, 2025
Eli Lilly$7.3BDec 31, 2025
AbbVie$5.2BDec 31, 2025
Vertex Pharmaceuticals Inc / Ma$5.1BDec 31, 2025

Questions and answers

What is Bristol Myers Squibb's cash?

Bristol Myers Squibb held $10.2B in cash and cash equivalents on Dec 31, 2025, down 1.3% from $10.3B a year earlier.

Numbers as reported in Bristol Myers Squibb's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology